Herceptin News

Date Posted
Article Title
5/18/2017
More U.S. Women Living Longer With Advanced Breast Cancer

Better treatments, aging population may explain promising trend, researchers say

6/3/2016
Cheaper Breast Cancer Drug Does Well in Clinical Trial

It has similar effectiveness, safety compared to Herceptin for HER2-positive disease

3/10/2016
Drug Duo May Rapidly Shrink Breast Tumors in Some Patients

Researchers say combo therapy worked well for about 1 in 4 women with HER2-positive breast cancer

10/20/2014
Herceptin Boosts Survival for Breast Cancer, Study Reports

Taking drug in addition to chemotherapy also reduces risk of cancer recurrence

9/30/2014
Herceptin Best for Certain Breast Cancer Patients, Study Says

Drug should remain standard of care for HER2-positive tumors, doctors say

6/10/2014
Breast Cancer Drug Herceptin Linked to Risk of Heart Problems: Study

But most of these effects reverse after women finish treatment, experts say

10/7/2013
Experts Urge Routine Test for All Patients With Invasive Breast Cancer

Standardized HER2 screen would help ensure women get appropriate therapy, guideline authors say

11/15/2012
Herceptin May Carry Higher Heart Risks for Women Than Thought

Breast cancer drug showed even greater chances of heart failure, cardiomyopathy among older patients

8/30/2012
Breast Cancer Drug May Harm the Heart More Than Thought

Analysis finds increased risk of cardiac problems with Herceptin in real-world setting

1/17/2012
Drug Duo May Help Fight Aggressive Form of Breast Cancer

Response rate increased with two-drug approach, researchers report

12/8/2011
Two New Drug Combos May Fight Advanced Breast Cancers

Studies found disease-free survival was lengthened when two new drugs were added to standard regimen

10/5/2011
Drug Combo Might Fight Aggressive Breast Cancer More Safely

Study suggests anthracyclines not needed to treat HER2-positive breast cancer, can pose heart risks

6/14/2011
FDA Approves Test That Spots Aggressive Breast Cancer

Genetic screen helps doctors find HER2-positive patients who will respond to Herceptin